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ABSTRACT 
Objective: Mycobacterium avium complex (MAC) is isolated 
with increasing frequency from respiratory specimens. This 
study was an attempt to determine the significance of this in 
human immunodeficiency virus (HIV)-positive and HIV-negative 
patients. 
Methods: A retrospective cohort study was conducted at Belle- 
vue Hospital, a large municipal hospital in New York City, includ- 
ing all patients with two or more respiratory tract specimens 
positive for MAC during the period January 1996 to October 
1996. 
Results: Eighty patients met inclusion criteria. Forty-six were 
HIV-positive, and 34 were HIV-negative. Age, gender distribu- 
tion, and race were comparable. Cough was a common com- 
plaint in all patients, whereas HIV-positive patients were 
significantly more likely to have fever (19 vs. 2, P < 0.0001). 
Abnormal chest radiographs were common in both groups (P 
> 0.8), although HIV-positive patients were more likely to have 
diffuse abnormalities (P < 0.0001). Focal radiographic findings 
were similar for both groups; however, there was a trend toward 
more lymphadenopathy in the HIV-positive group, though this 
did not reach statistical significance (P = 0.17). Notably, patients 
in both groups frequently had an established concurrent pul- 
monary diagnosis or evidence of disseminated MAC infection. 
Patients who were HIV-positive had Pneumocystis carinii pneu- 
monia (n = lo), pneumonia (n = lo), and disseminated MAC 
disease (n = 12); whereas the concurrent disease in HIV-neg- 
ative patients predominantly was active tuberculosis (n = 13). 
According to the recent American Thoracic Society-recom- 
mended criteria for the diagnosis of pulmonary disease caused 
by nontuberculous mycobacteria only 7 of 46 HIV-positive 
patients and 1 of 34 HIV-negative patients met clinical, bacterio- 
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logic, and radiographic criteria for pulmonary disease caused 
by MAC (P = 0.052). 
Conclusion: Mycobacterium avium complex often is cultured 
from patients with other lung diseases, and its presence in 
sputum infrequently signifies true disease, though it is more 
likely to do so in HIV-positive patients. 
Key Words: human immunodeficiency virus, Mycobacterium 
avium complex, Mycobacterium tuberculosis, nontuberculous 
mycobacteria 
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Nontuberculous mycobacteria (NTM) are ubiquitous 
organisms in the environment. They often are isolated 
from water and soil, and frequently have been isolated 
from respiratory tract specimens from persons with and 
without overt lung disease.lm3 More often than not, they 
have been considered airway colonizers rather than true 
pathogens, although clinical syndromes associated with 
several NTM are well known and well characterized.” 
Organisms belonging to the Mycobacterium avium 
complex (MAC) are the most frequently isolated of the 
NTM in clinical practice in the United States3 Increas- 
ingly, MAC has been implicated as a true pathogen in both 
immunocompetent and immunocompromised individu- 
als. This is reflected in the recently updated guidelines 
for diagnosis of disease attributable to NTM, published by 
the American Thoracic Society (ATS).5 It is possible that 
the apparently increased frequency of recovery of MAC 
from respiratory samples is related to improved profi- 
ciency in isolating and identifying mycobacteria, increased 
numbers and survival of immunocompromised patients 
with acquired immunodeficiency syndrome (AIDS), and 
prolonged survival of patients with underlying severe pul- 
monary disease. Despite this, the clinical syndromes asso- 
ciated with the isolation of MAC from respiratory tract 
specimens remain somewhat poorly defined, as many (par- 
ticularly in patients without AIDS) were characterized 
when culture techniques and imaging studies were not as 
sophisticated as those currently routinely available. In addi- 
tion, many early reports of pulmonary disease attributable 
to MAC represented highly selected series in which 
patients were chosen because of clear-cut pulmonary 
Significance of M. avium Isolates / Raju and Schluger 135 
syndromes or clinically worsening lung disease. These RESULTS 
studies have provided valuable information in terms of 
defining pulmonary syndromes caused by MAC (including Identification and Characterization 
the so-called Lady Windemere syndrome of lingular or of Study Population 
middle lobe infiltrates attributable to MAC in elderly 
women),6-8 but they have provided somewhat less infor- 
mation regarding the relative frequency of these syn- 
dromes compared with the isolation of MAC in respiratory 
samples in patients in general. 
To more completely determine the significance of 
recovery of MAC from sputum or bronchoscopic speci- 
mens, an investigation of the significance of this finding 
in patients with and without HIV infection was 
conducted. 
MATERIALS AND METHODS 
Reports from the microbiology laboratory at Bellevue Hos- 
pital (a large municipal hospital in New York City) were 
reviewed for respiratory tract isolates positive for MAC 
during the period from January to October 1996. Mycobac- 
terial cultures are performed using the broth-based MGIT 
culture system (Becton-Dickinson, Franklin Lakes, Nn and 
are speciated with nucleic acid probes (GemProbe, San 
Diego, CA). Patients with two or more sputum cultures 
or any one bronchoscopy specimen positive for MAC were 
identified to increase the likelihood of fmding patients 
with true disease as defined in the recently revised ATS 
guideline.5 
Having identified patients with deep or multiple res- 
piratory tract specimens positive for MAC, medical 
records of the patients were reviewed and relevant demo- 
graphic and clinical data were abstracted. Results of radio- 
graphic studies performed at the time of the initial 
positive MAC culture were reviewed. 
Patients were classified as having disease definitely, 
From January to October 1996, there were 648 respira- 
tory specimens from 3 19 patients that yielded growth of 
MAC organisms. Of these 3 19 patients, 117 met inclusion 
criteria for the study (two or more sputum samples or 
one or more bronchoscopy specimens positive for MAC); 
of these 117, medical records of 80 patients were avail- 
able for review. This cohort formed the study population. 
Although there were several charts not available for com- 
plete review, using the hospital’s computer database, it 
was possible to ascertain HIV status and radiographic 
findings for these patients, and the distribution of findings 
was not different from that among patients for whom 
complete records were available. However, since com- 
plete information was not available for this group, their 
data were not included in the overall results. 
Of the study population, there were 46 (58%) HIV- 
positive individuals and 34 (42%) HIV-negative individu- 
als. The demographic characteristics of the patients, 
stratified by HIV serostatus, are shown in Table 1. There 
were no statistically significant differences between HIV- 
positive and HIV-negative patients in the demographic 
features identified, and the demographic characteristics 
of HIV-positive patients with MAC were not different 
from those of patients with HIV seen at the hospital in 
general. 
Bacteriology 
The number of respiratory specimens yielding MAC from 
the study cohort of 80 patients was 277; the median num- 
ber of respiratory cultures positive for each patient in 
the study was three. Most of the positive MAC cultures 
Table 1. Characteristics of Study Patients 
Total (n = 80) 46 
Median age (y) (range) 36 (24-48) 
Gender 
Characteristics HIV-Positive HIV-Negative 
34 
41 (19-45) 
possibly, or unlikely attributable to infection with MAC 
organisms, according to the revised ATS criteria for the 
diagnosis of pulmonary disease attributable to non- 
tuberculous mycobacteria.5 These criteria include clini- 
cal symptoms (cough, fever, fatigue, weight loss, 
hemoptysis, or dyspnea not accounted for by other pul- 
monary disease), radiographic findings (cavitation, nod- 
ules, or progressive infiltrates on chest radiograph or 
multiple small nodules or multifocal bronchiectasis on 
chest computed tomography [CT]), and bacteriologic 
results (two or more positive sputum cultures, one pos- 
itive bronchoalveolar lavage @AL) culture, or one positive 
culture from a tissue biopsy specimen). Definite disease, 
as defined by the ATS guidelines, had evidence from all 
three components. Patients with definite pulmonary MAC 
were compared to patients in the study who did not ful- 
fill criteria for this diagnosis. 
Female (n = 12) 
Male (n = 68) 
Race/ethnicity* 
39 
5 
29 
Asian 
African-American 
Hispanic 
Caucasian 
HIV risk 
Heterosexual 
Homosexual 
IVDU 
Unknown 
Tobacco history 
26* 
17 
2 
11 
6 
19 
14 
9 
4 
0 
3 
12 30 
Statistical comparisons of independence were done 
by chi-square analysis. 
Nonsmoker 6 7 
Smoker 15 
Mean CD4 count (cells/mm3) (range) 21(02_q300) 
*P < 0.01 vs. HIV-negative. IVDU = intravenous drug user. 
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were obtained from sputum samples (264 samples total). 
Ten samples were obtained from cultures of BAL fluid 
or bronchial washings. Two cultures were obtained from 
transbronchial biopsy specimens, and one was from a 
mediastinal lymph node aspiration. 
Clinical Features of Patients 
Cough, chills, and a variety of nonspecific complaints 
were fairly common among both HIV-positive and HIV- 
negative patients in the study (Table 2). However, fever 
was observed more often among HIV-positive patients. 
Among concurrent pulmonary diagnoses at the time 
MAC was isolated from a respiratory sample, tuberculo- 
sis and bacterial pneumonia were common in both 
groups (Table 3). Patients with AIDS also frequently had 
disseminated MAC infection or Pneumocystis curinii 
pneumonia (PCP). The overall likelihood of having a con- 
current pulmonary diagnosis did not differ between HIV- 
positive and HIV-negative patients. 
Radiographic Findings 
Abnormal radiographic findings were common in both 
HIV-negative and HIV-positive patients (Table 4). Patients 
with AIDS were more likely to have diffuse infiltrates, 
probably reflecting the high incidence of l? curinii pneu- 
monia in this group. Several patients obviously had more 
than one abnormality noted on chest radiograph. 
Thirty-two of the 80 patients in the cohort had CT 
scans of the chest, and these results also were reviewed. 
In general, CT findings were similar to those seen on 
plain chest radiographs. However, CT scans identified 13 
patients with mediastinal adenopathy (10 of whom were 
HIV-positive), whereas this finding was noted on the plain 
films of only nine patients. 
Diagnostic Classification of Patients 
After review of the above data on a case-by-case basis, 
the patients were classified into two groups: those with 
definite evidence of MAC pulmonary disease (based on 
the ATS guidelines) or those not meeting the diagnostic 
Table 2. Symptoms Reported by Patients 
Symptoms HIV- Positive H/V-Negative 
Fever (n = 21) 
Cough (n = 14) 
Chills (n = 10) 
Night sweats (n = 8) 
Change in sputum (n = 7) 
Weight loss (n = 6) 
Anorexia (n = 3) 
Hemoptysis (n = 2) 
Dizziness (n = 2) 
Fatigue (n = 1) 
Other (n = 3) 
19* 2 
9 5 
9 1 
7 1 
3 4 
5 1 
2 1 
1 1 
2 0 
1 0 
2 1 
*P < 0.01 vs. HIV-negative; all others not significant. 
Table 3. Concurrent Pulmonary Diagnoses 
Diagnosis HIV-Positive HIV-Negative 
Asthma exacerbation (n = 3) 2 1 
f? carinii pneumonia (n = 10) 10* 0 
Pneumonia (n = 13) 10 3 
Tuberculosis 
Active (n = 20) 7 13 
Inactive (n = 5) 2 3 
Sarcoidosis (n = 1) 0 1 
Herpes pneumonitis (n = 1) 1 0 
Acute bronchitis (n = 6) 4 2 
COPD(n=l) 0 1 
*P < 0.05 vs. HIV-negative; all others not significant. COPD = chronic 
obstructive pulmonary &ease. 
criteria. Table 5 presents these classifications along with 
the summary characteristics of the patients in the two 
categories. Of the 80 patients in the study, only eight 
(10%) could be classified as having definite pulmonary 
MAC disease. Of these, seven were HIV-positive and only 
one was HlV-negative. Overall, only 1 of 34 (3%) HIV-neg- 
ative patients with multiple positive sputums or BAL cul- 
tures met ATS criteria for pulmonary MAC. Of patients 
with AIDS, 7 of 46 (15%) HIV patients met ATS criteria, 
although three of the seven also had disseminated infec- 
tion, as evidenced by positive blood cultures for M avium 
complex, so that only 4 of 46 (8.7%) could be said to 
have isolated MAC pulmonary disease. The patients with 
MAC cultured from both blood and sputum not classi- 
fied as having MAC lung disease had another pulmonary 
diagnosis that was believed to explain the radiographic 
abnormalities. These diagnoses were: PCP bacterial pneu- 
monia, tuberculous adenitis, and herpes pneumonitis. 
Three had no radiographic findings at the time of the 
positive sputum cultures. Of the seven HIV-positive 
patients who met criteria for MAC pulmonary disease, 
all but one had CD4+ cell counts of less than 40/mm” 
(mean: 33/mm3; range: 0- 1 30/mm3). 
Interestingly, of the cohort of 80 patients, 16 had spu- 
tum smears that were positive for acid-fast bacilli. Of 
these, only one occurred in a patient ultimately deemed 
to have true MAC pulmonary disease. Thus, a positive 
sputum smear was not predictive of MAC pulmonary dis- 
ease in this cohort. 
Patients with definite MAC pulmonary disease had 
chest radiographs that most often demonstrated mediastinal 
Table 4. Chest Radiograph Findings 
Findings HIV- Positive HIV-Negative 
Normal (n = 14) 8 6 
Bronchiectasis (n = 2) 1 1 
Cavity (n = 3) 1 2 
Diffuse infiltrate (n = 20) 18* 2 
Focal infiltrate (n = 23) 10 13 
Lymphadenopathy (n = 9) 7 2 
Nodules (n = 11) 5 6 
*P < 0.05 vs. HIV-negative; all others not significant. 
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Table 5. Characteristics of Patients by Diagnostic Category 
MAC Lung No Definite 
Disease MAC Lung Disease 
(n = 8) (70%) (n = 72) (90%) 
HIV status 
Negative 
Positive 
Symptoms 
Fever 
Weight loss 
Chills 
Cough 
Night sweats 
Radiographic findings 
Normal 
Diffuse nodular opacities 
Lymphadenopathy 
Bronchiectasis 
Focal opacities 
Cavitary lesions 
Other diagnoses 
Pneumonia 
Tuberculosis 
Previous 
Current 
PCP 
Bronchitis 
Asthma exacerbation 
COPD 
Herpes pneumonitis 
Sarcoid 
Pulmonary fibrosis 
Disseminated MAC 
1 (12.5) 
7 (87.5) 
6 (75.0) 
2 (25.0) 
2 (25.0) 
3 (37.5) 
1 (12.5) 
0 (0) 
5 (62.5) 
3 (37.5) 
0 (0) 
1 (12.5) 
1 (12.5) 
0 
0 
0 
3 
33 (46.0) 
39 (54.0) 
15 (21 .O) 
4 (5.5) 
8(11.1) 
11 (15.0) 
7 (9.7) 
14 (19.4) 
15 (20.8) 
6 (8.3) 
2 (2.7) 
31 (43.0) 
2 (2.7) 
13 (18.0) 
5 (6.9) 
20 (27.7) 
10 (13.8) 
6 (8.3) 
3 (4.1) 
1 (1.4) 
I [i,4j 
1 (1.4) 
2 (2.7) 
9 (12.5) 
MAC = Mycobacterium avium; HIV = human immunodeficiency virus: 
PCP = Pneumocystis carinii pneumonia; COPD = chronic obstructive 
pulmonary disease. 
lymphadenopathy or focal nodular infiltrates, which might 
mimic pulmonary tuberculosis (Figures 1 and 2). This 
was in contrast to patients who did not fulfill criteria for 
pulmonary MAC disease; these patients more often had 
normal chest radiographs or focal opacities typical of rou- 
Figure 1. Chest computed tomography scan of an HIV-positive 
patient (CD4+ cells = 20/mm3) with five induced sputum samples cul- 
ture positive for MAC and no evidence of any other cause of pulmonaty 
disease. Note evidence of a right middle lobe infiltrate. 
Figure 2. Computed tomography scan of the chest of a patient with 
mediastinal lymphadenitis caused by M. avium complex. Mediastinal 
view shows enlarged subcarinal lymph node with central necrosis. 
tine bacterial pneumonia. Fever and cough were the most 
common clinical complaints in patients with definite dis- 
ease, but these symptoms also were common in patients 
with airway colonization with MAC and other pulmonary 
diagnoses. This is not surprising given the nonspecific 
nature of these complaints. 
DISCUSSION 
This study was performed to determine the frequency 
and significance of multiple respiratory tract specimens 
that yielded growth of M. avium complex organisms. The 
study produced several interesting findings. In a lo-month 
period, the hospital laboratory reported a large number 
of positive cultures from respiratory specimens that grew 
MAC isolates: 648 from 3 19 patients. This far exceeds the 
number of cultures positive for Mycobacterium tuber- 
culosis (or any other nontuberculous mycobacteria) iden- 
tified in the hospital during the same period. In fact, such 
a high rate of recovery of MAC seems to represent a rel- 
atively recent trend, though precise data on the frequency 
of recovery of MAC are difficult to obtain, because disease 
attributable to M. avium complex is not a reportable con- 
dition in the United StateszJ The increasingly high rates 
of recovery of MAC may be related to several factors, 
including a higher prevalence of this organism in the 
environment (particularly in water supplies), higher rates 
of person-to-person transmission (though historically this 
mode of spread has not been considered to be likely), and 
possibly the use of more sensitive broth-based culture 
techniques. 
Despite the frequency of recovery of MAC in spu- 
tum samples, only a minority of patients met ATS crite- 
ria for diagnosis of actual pulmonary disease attributable 
to MAC. In fact, many of the patients had other pulmonary 
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illnesses at the time of evaluation for MAC. In this light, 
the range of symptoms and radiographic findings in the 
present cohort should not be taken to represent MAC- 
specific findings, and the reader is cautioned always to 
consider alternate diagnoses in patients from whom MAC 
is recovered in a respiratory sample. Interestingly, a diag- 
nosis of MAC was more likely in patients with HIV infec- 
tion than in immunocompetent hosts. Although MAC 
bacteremia is a well-described source of morbidity and 
mortality in patients with AIDS9 MAC pulmonary dis- 
ease, particularly without evidence of disseminated infec- 
tion, occurs less frequently In fact, previous studies report 
that isolated MAC pulmonary disease in patients with 
AIDS is unu~ual.‘~-‘* The authors of a previous study iden- 
titled 53 patients with HIV infection with multiple spu- 
tum cultures positive for MAC in a 24-month period. Of 
these, five (9.4%) were determined to have pulmonary 
disease without dissemination, a frequency remarkably 
close to that found in the present study. Strikingly how- 
ever, the patients in the present study were identified in 
less than half the time it took to assemble a cohort in the 
previous report, perhaps indicating regional differences 
in the importance of this pathogen.‘* 
The significance of pulmonary MAC disease as an 
isolated cause of morbidity and mortality is not well 
described, and the pathologic or cause-and-effect relation 
between pulmonary MAC infection and disseminated dis 
ease is not well defined. Whereas respiratory coloniza- 
tion with MAC seems to be a predictor of the 
development of disseminated disease, the frequency of 
pulmonary involvement in disseminated disease has been 
reported to range only between 1.3% and 8.5%.‘O-‘* 
Radiographic findings in MAC pulmonary disease asso- 
ciated with HIV infection differ markedly from the clas- 
sic findings associated with the so-called Lady Windemere 
syndr0me.s In the present study, the most common radio- 
graphic fmdings were mediastinal adenopathy or nodular 
infiltrates. This also differs from recently described pat- 
terns of a “tree in bud” appearance linked to bronchiolitis 
associated with MAC infection that often occurs with 
bronchiectasis.r5-*’ The nodular disease and mediastinal 
adenopathy can certainly mimic the manifestations of dis- 
ease caused by M. tuberculosis in patients with HIV infec- 
tion,*l and clinicians should consider both mycobacteria 
when these radiographic findings are accompanied by the 
report of a positive acid-fast smear from a respiratory sam- 
ple. In such cases, a nucleic acid amplification assay may 
be helpful in rapidly distinguishing M. tuberculosis from 
M. auium complex organisms.22 
Most of the HIV-infected patients in whom a diag- 
nosis of pulmonary MAC disease was made had advanced 
AIDS, as manifested by the low CD4+ T-cell counts. In 
this regard, these patients are similar to those at risk of 
developing disseminated MAC, which usually occurs with 
CD4+ T-cell counts of less than 50/mtn’.9~23~24 
CONCLUSION 
It has been demonstrated that isolation of MAC from res- 
piratory samples is now common, and many of the 
patients have multiple sputum cultures positive for M. 
avium complex. However, despite this apparent increased 
frequency of recovery of MAC, most patients from whom 
this organism is recovered do not meet ATS criteria for 
defmite pulmonary disease. Although isolated pulmonary 
MAC disease is stih uncommon in patients with HIV infec- 
tion, it should be in the differential diagnosis of radio- 
graphic abnormalities and a positive acid-fast smear in 
this patient population. 
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